Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid

被引:5
|
作者
Mallett, MS
Hagan, RL
Peters, DA
机构
[1] WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,MORRIS PLAINS,NJ 07950
[2] DAVID GRANT MED CTR,DEPT PHARM,PHARM SUPPORT SERV,CLIN INVEST FACIL,TRAVIS AFB,CA
关键词
capsules; cholelitholytic agents; compounding; formulations; glycerin; incompatibilities; orange syrup; stability; storage; suspending agents; suspensions; sweetening agents; temperature; ursodiol; vehicles;
D O I
10.1093/ajhp/54.12.1401
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The stability of ursodiol in an extemporaneously formulated oral liquid was studied. A suspension was prepared by combining the contents of commercially available 300-mg capsules of ursodiol with glycerin, Ora-Plus (Paddock Laboratories), and orange syrup. A second formulation was prepared by combining ursodiol capsules with sterile water for irrigation. The final concentration of ursodiol in each formulation was 25 mg/mL. Six samples of each preparation were stored in 4-oz amber plastic prescription bottles protected from light. Three were stored at 22-23 degrees C and three were refrigerated al 2-6 degrees C. Immediately after preparation and at 7, 15, 30, 45, and 60 days, samples were obtained and frozen until assay by high-performance liquid chromatography. On day 60 the mean percentage of the initial ursodiol concentration remaining was 108.4% for the suspension stored at room temperature and 103.3% for the refrigerated suspension. The ursodiol-in-water formulation was not analyzed because of rapid settling of ursodiol. Ursodiol 25 mg/mL in an oral liquid prepared extemporaneously from capsules and sweetened vehicle was stable for 60 days when stored in amber plastic bottles at 22-23 and 2-6 degrees C. Addition of ursodiol powder to water without a suspending agent resulted in a liquid formulation with a high variability in content uniformity.
引用
收藏
页码:1401 / 1404
页数:4
相关论文
共 50 条
  • [1] STABILITY OF URSODIOL IN AN EXTEMPORANEOUSLY COMPOUNDED ORAL LIQUID
    JOHNSON, CE
    NESBITT, J
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (16) : 1798 - 1800
  • [2] STABILITY OF FAMOTIDINE IN AN EXTEMPORANEOUSLY PREPARED ORAL LIQUID
    QUERCIA, RA
    JAY, GT
    FAN, CD
    CHOW, MSS
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (04): : 691 - 693
  • [3] Stability of norfloxacin in an extemporaneously prepared oral liquid
    Johnson, CE
    Price, J
    Hession, JM
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (07) : 577 - 579
  • [4] Stability of omeprazole in an extemporaneously prepared oral liquid
    Quercia, RA
    Fan, CD
    Liu, XC
    Chow, MSS
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (16) : 1833 - 1836
  • [5] STABILITY OF FLUCONAZOLE IN AN EXTEMPORANEOUSLY PREPARED ORAL LIQUID
    YAMREUDEEWONG, W
    LOPEZANAYA, A
    RAPPAPORT, H
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (11): : 2366 - 2367
  • [6] Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid
    Quercia, RA
    Zhang, JH
    Fan, CD
    Chow, MSS
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (12) : 1404 - 1406
  • [7] Formulation and stability evaluation of an extemporaneously prepared baclofen suspension (1 mg/mL)
    Purohit, Trusha J.
    Thakur, Sachin S.
    Carruth, Jonathan
    Dean, Farhan
    Kim, Darin
    Lee, Seunghyun
    Liu, Colin
    Sharma, Manisha
    Hanning, Sara M.
    JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2021, 51 (04) : 314 - 320
  • [8] Stability and Osmolality of Extemporaneously Prepared Clonidine Oral Liquid for Neonates
    Sauberan, Jason B.
    Phuong, Patrick
    Ilog, Nina D.
    Rossi, Steven S.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (03) : 243 - 244
  • [9] Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 °C
    Nahata, MC
    Morosco, RS
    Trowbridge, JM
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (12) : 1141 - 1143
  • [10] Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 °C
    Abdel-Rahman, SM
    Nahata, MC
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (03) : 243 - 245